Literature DB >> 14646190

Effects of intake of a mixture of thiamin, arginine, caffeine, and citric acid on adiposity in healthy subjects with high percent body fat.

Koutarou Muroyama1, Shinji Murosaki, Yoshihiro Yamamoto, Akitoshi Ishijima, Yasuo Toh.   

Abstract

We assessed the effects of intake of thiamin, arginine, caffeine, and citric acid (TACC) on lipid metabolism in healthy subjects. Thirty-one subjects with high percent body fat (> or = 25.0%) were randomly assigned to a 12-wk intervention with daily intake of TACC-supplemented tea (1.1, 1240, 52, and 540 mg, respectively; n=16) or control tea (n=15). The percent body fat decreased significantly during the intervention in both groups, especially in the TACC group. A percentage decrease in triceps skinfold was significantly greater in the TACC group than in the control group. The decrease in abdominal visceral fat in obese subjects was significantly greater in the TACC group than in the control group. Serum triglyceride was significantly lower during intervention than that during the non-intervention period in the TACC group. These results suggest that TACC may be effective in reducing body fat in obese subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646190     DOI: 10.1271/bbb.67.2325

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

Review 1.  Caffeine in tea Camellia sinensis--content, absorption, benefits and risks of consumption.

Authors:  A Gramza-Michałowska
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

2.  Adenosine signaling contributes to ethanol-induced fatty liver in mice.

Authors:  Zhongsheng Peng; Pier Andrea Borea; Katia Varani; Tuere Wilder; Herman Yee; Luis Chiriboga; Michael R Blackburn; Gianfranco Azzena; Giuseppe Resta; Bruce N Cronstein
Journal:  J Clin Invest       Date:  2009-02-16       Impact factor: 14.808

3.  Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.

Authors:  Tatsuya Ohara; Koutarou Muroyama; Yoshihiro Yamamoto; Shinji Murosaki
Journal:  Nutr J       Date:  2016-01-19       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.